TCF7 and pulmonary arterial hypertension: Therefore, our finding that TCF7 is hypermethylated, and that the expression of TCF7 is downregulated in the blood of PAH patients, implies that this may be a mechanism by which elevated Th1 and Th17 cells contribute towards the pro‐inflammatory phenotype common to this disease.